|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 101 to 200 out of 2609 for Mtor

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.044s

Categories

Category: Publication
« show all
Type Details Score
Publication
26356530 | J:226406
First Author: Wang S
Year: 2015
Journal: PLoS Biol
Title: Insulin and mTOR Pathway Regulate HDAC3-Mediated Deacetylation and Activation of PGK1.
Volume: 13
Issue: 9
Pages: e1002243
•
•
•
•
•
Publication
25349289 | J:219659
First Author: Marhold M
Year: 2015
Journal: Mol Cancer Res
Title: HIF1α Regulates mTOR Signaling and Viability of Prostate Cancer Stem Cells.
Volume: 13
Issue: 3
Pages: 556-64
•
•
•
•
•
Publication
26122641 | J:318793
First Author: He L
Year: 2015
Journal: Virol Sin
Title: mTOR regulates TLR-induced c-fos and Th1 responses to HBV and HCV vaccines.
Volume: 30
Issue: 3
Pages: 174-89
•
•
•
•
•
Publication
33150381 | J:303758
First Author: Liu L
Year: 2020
Journal: Blood
Title: ER-associated degradation preserves hematopoietic stem cell quiescence and self-renewal by restricting mTOR activity.
Volume: 136
Issue: 26
Pages: 2975-2986
•
•
•
•
•
Publication
35869262 | J:327347
First Author: Wang Y
Year: 2022
Journal: Commun Biol
Title: mTOR contributes to endothelium-dependent vasorelaxation by promoting eNOS expression and preventing eNOS uncoupling.
Volume: 5
Issue: 1
Pages: 726
•
•
•
•
•
Publication
25456069 | J:220762
First Author: Dominick G
Year: 2015
Journal: Endocrinology
Title: Regulation of mTOR activity in Snell dwarf and GH receptor gene-disrupted mice.
Volume: 156
Issue: 2
Pages: 565-75
•
•
•
•
•
Publication
25906314 | J:321668
First Author: Wang S
Year: 2015
Journal: Autophagy
Title: Reciprocal regulation of cilia and autophagy via the MTOR and proteasome pathways.
Volume: 11
Issue: 4
Pages: 607-16
•
•
•
•
•
Publication
33303641 | J:314680
First Author: Kon N
Year: 2021
Journal: Genes Dev
Title: mTOR inhibition acts as an unexpected checkpoint in p53-mediated tumor suppression.
Volume: 35
Issue: 1-2
Pages: 59-64
•
•
•
•
•
Publication
21439266 | J:171923
First Author: Uddin MN
Year: 2011
Journal: Biochem Biophys Res Commun
Title: Gadd34 induces autophagy through the suppression of the mTOR pathway during starvation.
Volume: 407
Issue: 4
Pages: 692-8
•
•
•
•
•
Publication
19704009 | J:153992
First Author: Liu GH
Year: 2009
Journal: Mol Cell Biol
Title: Regulation of myoblast differentiation by the nuclear envelope protein NET39.
Volume: 29
Issue: 21
Pages: 5800-12
•
•
•
•
•
Publication
20008564 | J:162918
First Author: Risson V
Year: 2009
Journal: J Cell Biol
Title: Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy.
Volume: 187
Issue: 6
Pages: 859-74
•
•
•
•
•
Publication
27875531 | J:237194
First Author: Ugolino J
Year: 2016
Journal: PLoS Genet
Title: Loss of C9orf72 Enhances Autophagic Activity via Deregulated mTOR and TFEB Signaling.
Volume: 12
Issue: 11
Pages: e1006443
•
•
•
•
•
Publication
26043155 | J:325870
First Author: Matsuzawa Y
Year: 2015
Journal: Autophagy
Title: TNFAIP3 promotes survival of CD4 T cells by restricting MTOR and promoting autophagy.
Volume: 11
Issue: 7
Pages: 1052-62
•
•
•
•
•
Publication
31527800 | J:287474
First Author: Kosinsky RL
Year: 2020
Journal: Cell Death Differ
Title: USP22 exerts tumor-suppressive functions in colorectal cancer by decreasing mTOR activity.
Volume: 27
Issue: 4
Pages: 1328-1340
•
•
•
•
•
Publication
20498714 | J:160830
First Author: Squarize CH
Year: 2010
Journal: PLoS One
Title: Accelerated wound healing by mTOR activation in genetically defined mouse models.
Volume: 5
Issue: 5
Pages: e10643
•
•
•
•
•
Publication
30141265 | J:277296
First Author: Li Z
Year: 2019
Journal: Hepatology
Title: mTOR Signaling in X/A-Like Cells Contributes to Lipid Homeostasis in Mice.
Volume: 69
Issue: 2
Pages: 860-875
•
•
•
•
•
Publication
27358481 | J:246193
First Author: Guo J
Year: 2016
Journal: J Cell Sci
Title: Oocyte-dependent activation of MTOR in cumulus cells controls the development and survival of cumulus-oocyte complexes.
Volume: 129
Issue: 16
Pages: 3091-103
•
•
•
•
•
Publication
19567830 | J:150809
First Author: Cobbold SP
Year: 2009
Journal: Proc Natl Acad Sci U S A
Title: Infectious tolerance via the consumption of essential amino acids and mTOR signaling.
Volume: 106
Issue: 29
Pages: 12055-60
•
•
•
•
•
Publication
29784807 | J:263006
First Author: Guo J
Year: 2018
Journal: Proc Natl Acad Sci U S A
Title: Oocyte stage-specific effects of MTOR determine granulosa cell fate and oocyte quality in mice.
Volume: 115
Issue: 23
Pages: E5326-E5333
•
•
•
•
•
Publication
27294611 | J:236258
First Author: Shan T
Year: 2016
Journal: Diabetologia
Title: Adipocyte-specific deletion of mTOR inhibits adipose tissue development and causes insulin resistance in mice.
Volume: 59
Issue: 9
Pages: 1995-2004
•
•
•
•
•
Publication
24569105 | J:212023
First Author: Zhang Y
Year: 2014
Journal: J Leukoc Biol
Title: mTOR limits the recruitment of CD11b+Gr1+Ly6Chigh myeloid-derived suppressor cells in protecting against murine immunological hepatic injury.
Volume: 95
Issue: 6
Pages: 961-70
•
•
•
•
•
Publication
20388826 | J:162945
First Author: Lang CH
Year: 2010
Journal: Am J Physiol Endocrinol Metab
Title: Skeletal muscle protein balance in mTOR heterozygous mice in response to inflammation and leucine.
Volume: 298
Issue: 6
Pages: E1283-94
•
•
•
•
•
Publication
15254238 | J:92252
First Author: Murakami M
Year: 2004
Journal: Mol Cell Biol
Title: mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells.
Volume: 24
Issue: 15
Pages: 6710-8
•
•
•
•
•
Publication
27036037 | J:309407
First Author: Bajwa P
Year: 2016
Journal: Oncotarget
Title: Age related increase in mTOR activity contributes to the pathological changes in ovarian surface epithelium.
Volume: 7
Issue: 15
Pages: 19214-27
•
•
•
•
•
Publication
22407942 | J:184465
First Author: Lee SE
Year: 2012
Journal: Mol Reprod Dev
Title: mTOR is required for asymmetric division through small GTPases in mouse oocytes.
Volume: 79
Issue: 5
Pages: 356-66
•
•
•
•
•
Publication
21946849 | J:191696
First Author: Goodman CA
Year: 2011
Journal: J Physiol
Title: The role of skeletal muscle mTOR in the regulation of mechanical load-induced growth.
Volume: 589
Issue: Pt 22
Pages: 5485-501
•
•
•
•
•
Publication
25712478 | J:221048
First Author: Warth SC
Year: 2015
Journal: EMBO J
Title: Induced miR-99a expression represses Mtor cooperatively with miR-150 to promote regulatory T-cell differentiation.
Volume: 34
Issue: 9
Pages: 1195-213
•
•
•
•
•
Publication
31483294 | J:285397
First Author: Kim JK
Year: 2019
Journal: J Clin Invest
Title: Brain somatic mutations in MTOR reveal translational dysregulations underlying intractable focal epilepsy.
Volume: 129
Issue: 10
Pages: 4207-4223
•
•
•
•
•
Publication
25799227 | J:319914
First Author: Lim JS
Year: 2015
Journal: Nat Med
Title: Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy.
Volume: 21
Issue: 4
Pages: 395-400
•
•
•
•
•
Publication
17329361 | J:135060
First Author: Moumen A
Year: 2007
Journal: Development
Title: Met acts on Mdm2 via mTOR to signal cell survival during development.
Volume: 134
Issue: 7
Pages: 1443-51
•
•
•
•
•
Publication
15967113 | J:100163
First Author: Hu X
Year: 2005
Journal: Neoplasia
Title: mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma.
Volume: 7
Issue: 4
Pages: 356-68
•
•
•
•
•
Publication
23911927 | J:202698
First Author: Linares JF
Year: 2013
Journal: Mol Cell
Title: K63 polyubiquitination and activation of mTOR by the p62-TRAF6 complex in nutrient-activated cells.
Volume: 51
Issue: 3
Pages: 283-96
•
•
•
•
•
Publication
23562079 | J:198971
First Author: Chaveroux C
Year: 2013
Journal: Cell Metab
Title: Molecular and genetic crosstalks between mTOR and ERRα are key determinants of rapamycin-induced nonalcoholic fatty liver.
Volume: 17
Issue: 4
Pages: 586-98
•
•
•
•
•
Publication
30297433 | J:266525
First Author: Nagahama Y
Year: 2018
Journal: Proc Natl Acad Sci U S A
Title: Regnase-1 controls colon epithelial regeneration via regulation of mTOR and purine metabolism.
Volume: 115
Issue: 43
Pages: 11036-11041
•
•
•
•
•
Publication
22745686 | J:187806
First Author: Lang SM
Year: 2012
Journal: PLoS One
Title: Delayed recovery of skeletal muscle mass following hindlimb immobilization in mTOR heterozygous mice.
Volume: 7
Issue: 6
Pages: e38910
•
•
•
•
•
Publication
32868461 | J:298898
First Author: Zhao XF
Year: 2020
Journal: J Neurosci
Title: Microglial mTOR is Neuronal Protective and Antiepileptogenic in the Pilocarpine Model of Temporal Lobe Epilepsy.
Volume: 40
Issue: 40
Pages: 7593-7608
•
•
•
•
•
Publication
30236984 | J:272989
First Author: Sun X
Year: 2018
Journal: Biochem Biophys Res Commun
Title: Hepatic conditional knockout of ATF6 exacerbates liver metabolic damage by repressing autophage through MTOR pathway.
Volume: 505
Issue: 1
Pages: 45-50
•
•
•
•
•
Publication
24814708 | J:222009
First Author: Bisht K
Year: 2014
Journal: Biochem Biophys Res Commun
Title: Biliverdin modulates the expression of C5aR in response to endotoxin in part via mTOR signaling.
Volume: 449
Issue: 1
Pages: 94-9
•
•
•
•
•
Publication
26344767 | J:256665
First Author: Tsujimura K
Year: 2015
Journal: Cell Rep
Title: miR-199a Links MeCP2 with mTOR Signaling and Its Dysregulation Leads to Rett Syndrome Phenotypes.
Volume: 12
Issue: 11
Pages: 1887-901
•
•
•
•
•
Publication
30794695 | J:274241
First Author: Walker S
Year: 2019
Journal: PLoS One
Title: Targeting mTOR and Src restricts hepatocellular carcinoma growth in a novel murine liver cancer model.
Volume: 14
Issue: 2
Pages: e0212860
•
•
•
•
•
Publication
28606928 | J:247199
First Author: Chau GC
Year: 2017
Journal: J Cell Biol
Title: mTOR controls ChREBP transcriptional activity and pancreatic β cell survival under diabetic stress.
Volume: 216
Issue: 7
Pages: 2091-2105
•
•
•
•
•
Publication
15156201 | J:90631
First Author: Majumder PK
Year: 2004
Journal: Nat Med
Title: mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways.
Volume: 10
Issue: 6
Pages: 594-601
•
•
•
•
•
Publication
25422441 | J:216801
First Author: Mullins GR
Year: 2014
Journal: Proc Natl Acad Sci U S A
Title: Catecholamine-induced lipolysis causes mTOR complex dissociation and inhibits glucose uptake in adipocytes.
Volume: 111
Issue: 49
Pages: 17450-5
•
•
•
•
•
Publication
26687947 | J:329116
First Author: Nakadera E
Year: 2016
Journal: Biochem Biophys Res Commun
Title: Inhibition of mTOR improves the impairment of acidification in autophagic vesicles caused by hepatic steatosis.
Volume: 469
Issue: 4
Pages: 1104-10
•
•
•
•
•
Publication
19586661 | J:151711
First Author: Delgoffe GM
Year: 2009
Journal: Mol Immunol
Title: Enhanced interaction between Hsp90 and raptor regulates mTOR signaling upon T cell activation.
Volume: 46
Issue: 13
Pages: 2694-8
•
•
•
•
•
Publication
25002183 | J:215643
First Author: Zhang CS
Year: 2014
Journal: Cell Metab
Title: The lysosomal v-ATPase-Ragulator complex is a common activator for AMPK and mTORC1, acting as a switch between catabolism and anabolism.
Volume: 20
Issue: 3
Pages: 526-40
•
•
•
•
•
Publication
22307628 | J:182033
First Author: Zhang C
Year: 2012
Journal: Proc Natl Acad Sci U S A
Title: Glycerolipid signals alter mTOR complex 2 (mTORC2) to diminish insulin signaling.
Volume: 109
Issue: 5
Pages: 1667-72
•
•
•
•
•
Publication
28798047 | J:244375
First Author: Sinclair C
Year: 2017
Journal: Science
Title: mTOR regulates metabolic adaptation of APCs in the lung and controls the outcome of allergic inflammation.
Volume: 357
Issue: 6355
Pages: 1014-1021
•
•
•
•
•
Publication
26868297 | J:240076
First Author: Lakshmipathi J
Year: 2016
Journal: Diabetes
Title: PKCζ Is Essential for Pancreatic β-Cell Replication During Insulin Resistance by Regulating mTOR and Cyclin-D2.
Volume: 65
Issue: 5
Pages: 1283-96
•
•
•
•
•
Publication
30461220 | J:288239
First Author: Zhang Q
Year: 2019
Journal: J Cachexia Sarcopenia Muscle
Title: Lack of muscle mTOR kinase activity causes early onset myopathy and compromises whole-body homeostasis.
Volume: 10
Issue: 1
Pages: 35-53
•
•
•
•
•
Publication
24578415 | J:232294
First Author: Lakhani R
Year: 2014
Journal: EMBO Mol Med
Title: Defects in GABA metabolism affect selective autophagy pathways and are alleviated by mTOR inhibition.
Volume: 6
Issue: 4
Pages: 551-66
•
•
•
•
•
Publication
15928081 | J:99727
First Author: Feng Z
Year: 2005
Journal: Proc Natl Acad Sci U S A
Title: The coordinate regulation of the p53 and mTOR pathways in cells.
Volume: 102
Issue: 23
Pages: 8204-9
•
•
•
•
•
Publication
33823141 | J:311383
First Author: van Vliet T
Year: 2021
Journal: Mol Cell
Title: Physiological hypoxia restrains the senescence-associated secretory phenotype via AMPK-mediated mTOR suppression.
Volume: 81
Issue: 9
Pages: 2041-2052.e6
•
•
•
•
•
Publication
26314207 | J:248664
 
First Author: Sutton LP
Year: 2015
Journal: Neuropharmacology
Title: Essential role of D1R in the regulation of mTOR complex1 signaling induced by cocaine.
Volume: 99
Pages: 610-9
•
•
•
•
•
Publication
29463562 | J:262092
First Author: Zhao Y
Year: 2018
Journal: Blood
Title: mTOR masters monocyte development in bone marrow by decreasing the inhibition of STAT5 on IRF8.
Volume: 131
Issue: 14
Pages: 1587-1599
•
•
•
•
•
Publication
20864032 | J:165255
First Author: Horejsí Z
Year: 2010
Journal: Mol Cell
Title: CK2 phospho-dependent binding of R2TP complex to TEL2 is essential for mTOR and SMG1 stability.
Volume: 39
Issue: 6
Pages: 839-50
•
•
•
•
•
Publication
29844370 | J:262859
First Author: Chapman NM
Year: 2018
Journal: Nat Commun
Title: mTOR coordinates transcriptional programs and mitochondrial metabolism of activated Treg subsets to protect tissue homeostasis.
Volume: 9
Issue: 1
Pages: 2095
•
•
•
•
•
Publication
21501832 | J:273483
First Author: Jaramillo M
Year: 2011
Journal: Cell Host Microbe
Title: Leishmania repression of host translation through mTOR cleavage is required for parasite survival and infection.
Volume: 9
Issue: 4
Pages: 331-41
•
•
•
•
•
Publication
27035650 | J:234965
First Author: Craps J
Year: 2016
Journal: Endocrinology
Title: Involvement of mTOR and Regulation by AMPK in Early Iodine Deficiency-Induced Thyroid Microvascular Activation.
Volume: 157
Issue: 6
Pages: 2545-59
•
•
•
•
•
Publication
34032632 | J:308455
 
First Author: Akhaphong B
Year: 2021
Journal: JCI Insight
Title: Placental mTOR complex 1 regulates fetal programming of obesity and insulin resistance in mice.
Volume: 6
Issue: 13
•
•
•
•
•
Publication
29867114 | J:289055
First Author: Le Y
Year: 2018
Journal: Cell Death Dis
Title: Sorting nexin 10 controls mTOR activation through regulating amino-acid metabolism in colorectal cancer.
Volume: 9
Issue: 6
Pages: 666
•
•
•
•
•
Publication
29636366 | J:263188
First Author: Xiong Y
Year: 2018
Journal: J Lipid Res
Title: Adipocyte-specific DKO of Lkb1 and mTOR protects mice against HFD-induced obesity, but results in insulin resistance.
Volume: 59
Issue: 6
Pages: 974-981
•
•
•
•
•
Publication
25998386 | J:228449
First Author: Zhang P
Year: 2015
Journal: Biochem Biophys Res Commun
Title: mTOR is necessary for proper satellite cell activity and skeletal muscle regeneration.
Volume: 463
Issue: 1-2
Pages: 102-8
•
•
•
•
•
Publication
27538837 | J:235431
First Author: Callejas-Valera JL
Year: 2016
Journal: Carcinogenesis
Title: mTOR inhibition prevents rapid-onset of carcinogen-induced malignancies in a novel inducible HPV-16 E6/E7 mouse model.
Volume: 37
Issue: 10
Pages: 1014-25
•
•
•
•
•
Publication
25070845 | J:328771
First Author: Zhang X
Year: 2014
Journal: J Immunol
Title: CaMKIV-dependent preservation of mTOR expression is required for autophagy during lipopolysaccharide-induced inflammation and acute kidney injury.
Volume: 193
Issue: 5
Pages: 2405-15
•
•
•
•
•
Publication
24094105 | J:325325
First Author: Saxena S
Year: 2013
Journal: Neuron
Title: Neuroprotection through excitability and mTOR required in ALS motoneurons to delay disease and extend survival.
Volume: 80
Issue: 1
Pages: 80-96
•
•
•
•
•
Publication
25754821 | J:245845
First Author: Duan X
Year: 2015
Journal: Neuron
Title: Subtype-specific regeneration of retinal ganglion cells following axotomy: effects of osteopontin and mTOR signaling.
Volume: 85
Issue: 6
Pages: 1244-56
•
•
•
•
•
Publication
30257881 | J:269089
First Author: Hussain S
Year: 2018
Journal: Blood
Title: UCH-L1 bypasses mTOR to promote protein biosynthesis and is required for MYC-driven lymphomagenesis in mice.
Volume: 132
Issue: 24
Pages: 2564-2574
•
•
•
•
•
Publication
23197407 | J:232309
First Author: Wang RH
Year: 2013
Journal: EMBO Mol Med
Title: The orphan receptor TR3 participates in angiotensin II-induced cardiac hypertrophy by controlling mTOR signalling.
Volume: 5
Issue: 1
Pages: 137-48
•
•
•
•
•
Publication
21268018 | J:175427
First Author: Goldfinger M
Year: 2011
Journal: Eur J Immunol
Title: Protein synthesis in plasma cells is regulated by crosstalk between endoplasmic reticulum stress and mTOR signaling.
Volume: 41
Issue: 2
Pages: 491-502
•
•
•
•
•
Publication
20444807 | J:161324
First Author: Zullo A
Year: 2010
Journal: Hum Mol Genet
Title: Kidney-specific inactivation of Ofd1 leads to renal cystic disease associated with upregulation of the mTOR pathway.
Volume: 19
Issue: 14
Pages: 2792-803
•
•
•
•
•
Publication
23811944 | J:199145
First Author: Yuan H
Year: 2013
Journal: Cancer Res
Title: PPARδ induces estrogen receptor-positive mammary neoplasia through an inflammatory and metabolic phenotype linked to mTOR activation.
Volume: 73
Issue: 14
Pages: 4349-61
•
•
•
•
•
Publication
29712777 | J:262236
First Author: Umegaki Y
Year: 2018
Journal: J Neurosci
Title: Palladin Is a Neuron-Specific Translational Target of mTOR Signaling That Regulates Axon Morphogenesis.
Volume: 38
Issue: 21
Pages: 4985-4995
•
•
•
•
•
Publication
28101526 | J:255825
 
First Author: Chen W
Year: 2016
Journal: eNeuro
Title: Rapamycin-Resistant mTOR Activity Is Required for Sensory Axon Regeneration Induced by a Conditioning Lesion.
Volume: 3
Issue: 6
•
•
•
•
•
Publication
21511183 | J:171599
First Author: Li Q
Year: 2011
Journal: Immunity
Title: A central role for mTOR kinase in homeostatic proliferation induced CD8+ T cell memory and tumor immunity.
Volume: 34
Issue: 4
Pages: 541-53
•
•
•
•
•
Publication
20862226 | J:165117
 
First Author: Ma T
Year: 2010
Journal: PLoS One
Title: Dysregulation of the mTOR pathway mediates impairment of synaptic plasticity in a mouse model of Alzheimer's disease.
Volume: 5
Issue: 9
•
•
•
•
•
Publication
27690224 | J:238500
   
First Author: Yang J
Year: 2016
Journal: Elife
Title: Critical roles of mTOR Complex 1 and 2 for T follicular helper cell differentiation and germinal center responses.
Volume: 5
•
•
•
•
•
Publication
31296735 | J:280269
First Author: Vetters J
Year: 2019
Journal: J Exp Med
Title: The ubiquitin-editing enzyme A20 controls NK cell homeostasis through regulation of mTOR activity and TNF.
Volume: 216
Issue: 9
Pages: 2010-2023
•
•
•
•
•
Publication
33951440 | J:306662
First Author: Li K
Year: 2021
Journal: Cell Rep
Title: mTOR signaling regulates gastric epithelial progenitor homeostasis and gastric tumorigenesis via MEK1-ERKs and BMP-Smad1 pathways.
Volume: 35
Issue: 5
Pages: 109069
•
•
•
•
•
Publication
21040901 | J:167537
First Author: Lee JY
Year: 2010
Journal: Cell Stem Cell
Title: mTOR activation induces tumor suppressors that inhibit leukemogenesis and deplete hematopoietic stem cells after Pten deletion.
Volume: 7
Issue: 5
Pages: 593-605
•
•
•
•
•
Publication
34453483 | J:310345
First Author: Cabral WA
Year: 2021
Journal: Aging Cell
Title: Genetic reduction of mTOR extends lifespan in a mouse model of Hutchinson-Gilford Progeria syndrome.
Volume: 20
Issue: 9
Pages: e13457
•
•
•
•
•
Publication
34358226 | J:308519
First Author: Alqurashi RS
Year: 2021
Journal: PLoS One
Title: A Warburg-like metabolic program coordinates Wnt, AMPK, and mTOR signaling pathways in epileptogenesis.
Volume: 16
Issue: 8
Pages: e0252282
•
•
•
•
•
Publication
18468454 | J:136982
First Author: Cao R
Year: 2008
Journal: Mol Cell Neurosci
Title: Photic regulation of the mTOR signaling pathway in the suprachiasmatic circadian clock.
Volume: 38
Issue: 3
Pages: 312-24
•
•
•
•
•
Publication
23250913 | J:193290
First Author: Ching JK
Year: 2013
Journal: Hum Mol Genet
Title: mTOR dysfunction contributes to vacuolar pathology and weakness in valosin-containing protein associated inclusion body myopathy.
Volume: 22
Issue: 6
Pages: 1167-79
•
•
•
•
•
Publication
28758906 | J:247850
First Author: Hino K
Year: 2017
Journal: J Clin Invest
Title: Activin-A enhances mTOR signaling to promote aberrant chondrogenesis in fibrodysplasia ossificans progressiva.
Volume: 127
Issue: 9
Pages: 3339-3352
•
•
•
•
•
Publication
25573665 | J:342284
First Author: Vasheghani F
Year: 2015
Journal: Ann Rheum Dis
Title: PPARγ deficiency results in severe, accelerated osteoarthritis associated with aberrant mTOR signalling in the articular cartilage.
Volume: 74
Issue: 3
Pages: 569-78
•
•
•
•
•
Publication
16915281 | J:111744
First Author: Bernardi R
Year: 2006
Journal: Nature
Title: PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR.
Volume: 442
Issue: 7104
Pages: 779-85
•
•
•
•
•
Publication
23444404 | J:197572
First Author: Rosborough BR
Year: 2013
Journal: Blood
Title: Murine dendritic cell rapamycin-resistant and rictor-independent mTOR controls IL-10, B7-H1, and regulatory T-cell induction.
Volume: 121
Issue: 18
Pages: 3619-30
•
•
•
•
•
Publication
23425014 | J:218147
First Author: Caccamo A
Year: 2013
Journal: Aging Cell
Title: mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies.
Volume: 12
Issue: 3
Pages: 370-80
•
•
•
•
•
Publication
26961412 | J:250172
 
First Author: Matsushita Y
Year: 2016
Journal: Sci Rep
Title: Hyperactive mTOR signals in the proopiomelanocortin-expressing hippocampal neurons cause age-dependent epilepsy and premature death in mice.
Volume: 6
Pages: 22991
•
•
•
•
•
Publication
22058153 | J:181656
First Author: Schramm C
Year: 2012
Journal: Am J Physiol Heart Circ Physiol
Title: The PTPN11 loss-of-function mutation Q510E-Shp2 causes hypertrophic cardiomyopathy by dysregulating mTOR signaling.
Volume: 302
Issue: 1
Pages: H231-43
•
•
•
•
•
Publication
18347059 | J:136088
First Author: Yang TT
Year: 2008
Journal: Mol Cell Biol
Title: Integration of protein kinases mTOR and extracellular signal-regulated kinase 5 in regulating nucleocytoplasmic localization of NFATc4.
Volume: 28
Issue: 10
Pages: 3489-501
•
•
•
•
•
Publication
24504412 | J:211717
First Author: MacDonald EM
Year: 2014
Journal: Dis Model Mech
Title: Denervation atrophy is independent from Akt and mTOR activation and is not rescued by myostatin inhibition.
Volume: 7
Issue: 4
Pages: 471-81
•
•
•
•
•
Publication
23774212 | J:200612
First Author: Ghosh S
Year: 2013
Journal: Cancer Res
Title: mTOR signaling feedback modulates mammary epithelial differentiation and restrains invasion downstream of PTEN loss.
Volume: 73
Issue: 16
Pages: 5218-31
•
•
•
•
•
Publication
27048565 | J:259489
First Author: Morales CR
Year: 2016
Journal: Sci Signal
Title: Inhibition of class I histone deacetylases blunts cardiac hypertrophy through TSC2-dependent mTOR repression.
Volume: 9
Issue: 422
Pages: ra34
•
•
•
•
•
Publication
26577454 | J:316569
First Author: Madka V
Year: 2016
Journal: Cancer Prev Res (Phila)
Title: Targeting mTOR and p53 Signaling Inhibits Muscle Invasive Bladder Cancer In Vivo.
Volume: 9
Issue: 1
Pages: 53-62
•
•
•
•
•
Publication
15467718 | J:93907
First Author: Jacinto E
Year: 2004
Journal: Nat Cell Biol
Title: Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive.
Volume: 6
Issue: 11
Pages: 1122-8
•
•
•
•
•
Publication
24973821 | J:248728
First Author: Marçais A
Year: 2014
Journal: Nat Immunol
Title: The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells.
Volume: 15
Issue: 8
Pages: 749-757
•
•
•
•
•
Publication
20060329 | J:157634
First Author: Gulen MF
Year: 2010
Journal: Immunity
Title: The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activation.
Volume: 32
Issue: 1
Pages: 54-66
•
•
•
•
•
Publication
26732600 | J:317925
First Author: Wang X
Year: 2017
Journal: Mol Neurobiol
Title: Deletion of mTOR in Reactive Astrocytes Suppresses Chronic Seizures in a Mouse Model of Temporal Lobe Epilepsy.
Volume: 54
Issue: 1
Pages: 175-187
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom